Evaluation of Inflammatory Cells According to Phenotypes of Chronic Obstructive Pulmonary Disease

[1]  Fatma Merve Tepetam,et al.  Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation? , 2017, Tuberkuloz ve toraks.

[2]  R. Zhong,et al.  Comparisons of neutrophil‐, monocyte‐, eosinophil‐, and basophil‐ lymphocyte ratios among various systemic autoimmune rheumatic diseases , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[3]  Stephanie Law,et al.  Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. , 2017, Journal of thoracic disease.

[4]  J. Soriano,et al.  Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease , 2017 .

[5]  A. C. Tanrıkulu,et al.  Alterations of the neutrophil–lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients , 2017, The clinical respiratory journal.

[6]  F. Rashidi,et al.  Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. , 2017, Tuberkuloz ve toraks.

[7]  M. Qiu,et al.  Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis , 2017, Oncotarget.

[8]  Wei Xiong,et al.  Can we predict the prognosis of COPD with a routine blood test? , 2017, International journal of chronic obstructive pulmonary disease.

[9]  K. Davis,et al.  Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions , 2017, COPD.

[10]  M. Demir,et al.  Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. , 2016, Biomarkers in medicine.

[11]  B. Nordestgaard,et al.  Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. , 2016, American journal of respiratory and critical care medicine.

[12]  B. Ding,et al.  Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights , 2016, Expert review of respiratory medicine.

[13]  P. Gibson,et al.  Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2013, PloS one.

[14]  J. Soriano,et al.  Consensus document on the overlap phenotype COPD-asthma in COPD. , 2012, Archivos de bronconeumologia.

[15]  M. Miravitlles,et al.  Clinical Phenotypes of COPD: Identication, Denition and Implications for Guidelines , 2012 .

[16]  Karen Y. Stokes,et al.  Platelets: a critical link between inflammation and microvascular dysfunction , 2012, The Journal of physiology.

[17]  C. Briggs,et al.  Quality counts: new parameters in blood cell counting , 2009, International journal of laboratory hematology.

[18]  D. Halpin,et al.  Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. , 2008, Respiratory medicine.

[19]  K. Eagle,et al.  Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. , 2008, The American journal of cardiology.

[20]  C. Camargo,et al.  Mortality after an Emergency Department Visit for Exacerbation of Chronic Obstructive Pulmonary Disease , 2006, COPD.

[21]  Șahin,et al.  Relationship between hematological parameters and severity of chronic obstructive pulmonary disease , 2018 .

[22]  W. MacNee,et al.  Pathogenesis of chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.